Jazz Pharmaceuticals (JAZZ) Total Debt (2010 - 2026)
Jazz Pharmaceuticals' quarterly Total Debt came in at $5.4 billion in Q1 2026, little changed year-on-year from $5.4 billion in Q1 2025, and little changed quarter-over-quarter from $5.4 billion in Q4 2025.
Jazz Pharmaceuticals has reported Total Debt for 17 years, with the latest figure at $5.4 billion in Q1 2026.
- For the quarter ending Q1 2026, Total Debt changed 0.24% year-over-year to $5.4 billion; the trailing twelve-month figure through Mar 2026 stood at $5.4 billion (changed 0.24% YoY), and the FY2025 full-year result was $5.4 billion, down 12.28% from the prior year.
- Total Debt for Q1 2026 stood at $5.4 billion, roughly flat from $5.4 billion in the prior quarter.
- The five-year high for Total Debt was $6.1 billion in Q3 2024, with the low at $5.4 billion in Q1 2026.
- Average Total Debt over 5 years is $5.7 billion, with a median of $5.7 billion recorded in 2023.
- Year-over-year, Total Debt soared 186.63% in 2022 and slipped 12.28% in 2025.
- Tracing JAZZ's Total Debt over 5 years: stood at $5.7 billion in 2022, then fell by 0.2% to $5.7 billion in 2023, then climbed by 6.93% to $6.1 billion in 2024, then slipped by 12.28% to $5.4 billion in 2025, then dropped by 0.07% to $5.4 billion in 2026.
- The last three Total Debt figures came in at $5.4 billion (Q1 2026), $5.4 billion (Q4 2025), and $5.4 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 319.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 110.96 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.99 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Jazz Pharmaceuticals | 14.35 Bn | 12.51 Bn | 934.80 Mn | 5.35 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.35 Bn |
| Dec 31, 2025 | 5.36 Bn |
| Sep 30, 2025 | 5.36 Bn |
| Jun 30, 2025 | 5.36 Bn |
| Mar 31, 2025 | 5.37 Bn |
| Dec 31, 2024 | 6.11 Bn |
| Sep 30, 2024 | 6.11 Bn |
| Jun 30, 2024 | 5.71 Bn |
| Mar 31, 2024 | 5.71 Bn |
| Dec 31, 2023 | 5.71 Bn |
| Sep 30, 2023 | 5.72 Bn |
| Jun 30, 2023 | 5.72 Bn |
| Mar 31, 2023 | 5.72 Bn |
| Dec 31, 2022 | 5.72 Bn |
| Sep 30, 2022 | 5.73 Bn |
| Jun 30, 2022 | 6.02 Bn |
| Mar 31, 2022 | 6.02 Bn |
| Dec 31, 2021 | 6.05 Bn |
| Sep 30, 2021 | 6.28 Bn |
| Jun 30, 2021 | 6.74 Bn |
| Mar 31, 2021 | 2.10 Bn |
| Dec 31, 2020 | 2.09 Bn |
| Sep 30, 2020 | 2.09 Bn |
| Jun 30, 2020 | 2.10 Bn |
| Mar 31, 2020 | 1.61 Bn |
| Dec 31, 2019 | 1.61 Bn |
| Sep 30, 2019 | 1.60 Bn |
| Jun 30, 2019 | 1.60 Bn |
| Mar 31, 2019 | 1.60 Bn |
| Dec 31, 2018 | 1.60 Bn |
| Sep 30, 2018 | 1.59 Bn |
| Jun 30, 2018 | 1.59 Bn |
| Mar 31, 2018 | 1.58 Bn |
| Dec 31, 2017 | 1.58 Bn |
| Sep 30, 2017 | 1.58 Bn |
| Jun 30, 2017 | 1.67 Bn |
| Mar 31, 2017 | 1.88 Bn |
| Dec 31, 2016 | 2.03 Bn |
| Sep 30, 2016 | 2.18 Bn |
| Jun 30, 2016 | 1.18 Bn |
| Mar 31, 2016 | 1.18 Bn |
| Dec 31, 2015 | 1.19 Bn |
| Sep 30, 2015 | 1.29 Bn |
| Jun 30, 2015 | 1.37 Bn |
| Mar 31, 2015 | 1.34 Bn |
| Dec 31, 2014 | 1.34 Bn |
| Sep 30, 2014 | 1.34 Bn |
| Jun 30, 2014 | 1.20 Bn |
| Mar 31, 2014 | 1.20 Bn |
| Dec 31, 2013 | 549.98 Mn |
| Sep 30, 2013 | 551.14 Mn |
| Jun 30, 2013 | 552.30 Mn |
| Mar 31, 2013 | 451.16 Mn |
| Dec 31, 2012 | 456.76 Mn |
| Sep 30, 2012 | 462.35 Mn |
| Jun 30, 2012 | 467.94 Mn |
| Jun 30, 2011 | 4.00 Mn |
| Dec 31, 2010 | 48.04 Mn |